Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005460 |
YEM_ID: | YEM-471 |
XU_ID: | XU-441 |
ID: | TCMBANKHE005460/YEM-471/XU-441 |
植物拉丁名: |
|
功能与主治: | To harmonize center and check vomiting, dispel wind and relieve itch./Nausea and vomiting, wind papule itching. |
药用植物名: | 柚木 |
药名: | 柚木 |
来源: | 云南民族药物志：第三卷|云南省德宏州盈江县那邦镇铜壁关自然保护区 |
药用部位: | stem-leaf|叶 |
使用民族: | 傣族 |
KUMST_ID1: | KMUST-BS-0453 |
KUMST_ID2: | KMUST-2023121500098-1，-2 |
TCM_ID_id: | 2228 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN019633 | Deoxylapachol | 2-(3-methylbut-2-enyl)-1,4-naphthoquinone; 2-(3-methylbut-2-enyl)naphthalene-1,4-dione; deoxylapachol; 3568-90-9; NSC123507; NSC 123507; 1,4-Naphthalenedione, 2-(3-methyl-2-butenyl)-; C10325 | C15H14O2 | 226.27 | CC(=CCC1=CC(=O)C2=CC=CC=C2C1=O)C |
| TCMBANKIN030507 | (e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(2,2-dimethyl-8-hydroxy-2h-benzo-pyran-6-yl)-2-propen-1-one | (e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(2,2-dimethyl-8-hydroxy-2h-benzopyran-6-yl)-2-propen-1-one | C25H26O5 | CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=CC(=C3C(=C2)C=CC(O3)(C)C)O)O)C | |
| TCMBANKIN037382 | Aloeemodin | AC1Q6JR7; SMP2_000291; Aloe-emodol; 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone; DSSTox_RID_78855; AS-11638; NCGC00163510-02; HY-N0189; CCG-208456; Diacerein impurity B, European Pharmacopoeia (EP) Reference Standard; AJ-48016; DTXSID2030695; BC216172; TL8003252; 3-(Hydroxymethyl)chrysazin; MLS000697563; BBL027838; 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione; AK160272; 481-72-1; aloe emodine; MCULE-6965338444; RP29614; 1, 8-dihydroxy-3-hydroxymethylanthraquinone; BB_NC-2562; NCGC00255349-01; C10294; SR-01000765772; BG00617009; 9, 1,8-dihydroxy-3-(hydroxymethyl)-; ST24045939; DSSTox_CID_10695; Tox21_302400; NCGC00163510-03; Anthraquinone,8-dihydroxy-3-(hydroxymethyl)-; 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #; 1,8-Dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9CI; Aloeemodin; s2259; CS-3709; TR-031339; 1,8-Dihydroxy-3-hydroxymethylanthraquinone; 4-08-00-03578 (Beilstein Handbook Reference); AIDS-048396; InChI=1/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H; 1,8-dihydroxy-3-(hydroxymethyl)-9,10-anthrachinon; CAS-481-72-1; EINECS 207-571-7; UNII-C8IYT9CR7C; LMPK13040002; AC-020; NSC-38628; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene; 1,8-dihydroxy-3-methylol-9,10-anthraquinone; CCRIS 3526; AC1L1UPK; BG01563188; LS-2202; 1,8-dihydroxy-3-hydroxymethyl-anthraquinone; Aloe emodin; AX8006287; SR-01000765772-3; Q-100526; SC-46578; 3-Hydroxymethylchrysazin; Rhabarberone; AIDS048396; NSC 38628; BRN 2059062; C8IYT9CR7C; N1851; 1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione; AB0010470; Aloe-emodin, >=95% (HPLC); ZINC4098644; aloe emodin; HMS3655N16; D09BUG; CHEMBL40275; 1,8-Dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (Aloe-Emodin); NCGC00163510-01; MLS006011799; 1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone; AN-16215; NCI60_003685; Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,; cid_10207; 3-Hydroxymethylchrysazine; Aloe-emodin; SMR000470920; aloeemod-in; MFCD00017373; LMPK02000031; STL146380; 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-; MolPort-003-931-716; FT-0622062; aloe-emodin; API0001418; 1,8-dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone; Rottlerin?; ANTHRAQUINONE, 1,8-DIHYDROXY-3-HYDROXYMETHYL-; A7687_SIGMA; I14-1413; 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)- (9CI); CA-417; BDBM50085551; Aloe-emodine; YDQWDHRMZQUTBA-UHFFFAOYSA-N; NSC38628; Aloe-emodin, analytical standard; AKOS005720864; aloe-emodin ; SCHEMBL309756; 481A721; EMODINE; Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-; CHEBI:2607; DSSTox_GSID_30695; CA0128 | 270.24 | ||
| TCMBANKIN037430 | alpha-Lapachone | α-lapachone | C15H14O3 | 242.27 | c12c(c([H])c([H])c([H])c1[H])C(=O)C3=C(C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])O3)C2=O |
| TCMBANKIN040207 | Deoxyloganin | 374.4 g/mol | |||
| TCMBANKIN041527 | Chrysophanol-8-O-beta-D-(6'-O-galloyl)-glucopyranoside | [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(8-hydroxy-6-methyl-9,10-dioxo-1-anthryl)oxy]tetrahydropyran-2-yl]methyl 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(8-hydroxy-6-methyl-9,10-dioxo-1-anthryl)oxy]-2-tetrahydropyranyl]methyl ester; [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(8-hydroxy-6-methyl-9,10-dioxo-anthracen-1-yl)oxy-oxan-2-yl]methyl 3,4,5-trihydroxybenzoate; Chrysophanol 8-(6-O-galloyl-beta-D-glucopyranoside); [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(8-hydroxy-6-methyl-9,10-dioxoanthracen-1-yl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(8-hydroxy-9,10-diketo-6-methyl-1-anthryl)oxy]tetrahydropyran-2-yl]methyl ester; chrysophanol-8-o-beta-d-(6'-o-galloyl)-glucopyranoside; AC1NSTKE; CHEMBL109609 | C28H24O13 | 568.5 g/mol | CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3OC4C(C(C(C(O4)COC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)O |
| TCMBANKIN046263 | beta-Lapachone | KBio2_002594; EU-0100717; 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-B]pyran-5,6-dione; NCI60_009665; KBioSS_000026; β-lapachone; 5-17-11-00459 (Beilstein Handbook Reference); 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione; Lopac-L-2037; 2H-Naphtho[1,2-b]pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl-; AIDS027823; BCBcMAP01_000055; Bio2_000026; AIDS-027823; 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione; NSC 629749; LAPACHONE, BETA; 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl-; KBio3_000051; KBio2_000026; IDI1_033776; NCGC00094066-04; 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-quinone; QTL1_000048; .beta.-Lapachone; beta-lapachone; 4707-32-8; HSCI1_000182; NSC629749; Bio2_000506; L2037_SIGMA; BSPBio_001306; KBio2_005162; C10367; KBioGR_000026; KBio3_000052; NCGC00015598-01; Lopac0_000717; NSC 26326; BRN 0181499; NSC26326 | C15H14O3 | 242.27 | CC1(CCC2=C(O1)C3=CC=CC=C3C(=O)C2=O)C |
| TCMBANKIN058424 | L-2-Amino-3-(5-hydroxyindolyl)propionic acid | (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propionic acid; ST048776; NCGC00015526-01; NCGC00091062-04; CHEBI:17780; C00643; Lopac0_000627; NCGC00091062-01; Lopac-H-9772; (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid; H9772_SIGMA; 107751_ALDRICH; 56570_FLUKA; 4350-09-8; L-5-HTP; EU-0100627;5-hydroxy-l-tryptophan | C11H12N2O3 | 220.22 g/mol | C1=CC2=C(C=C1O)C(=CN2)CC(C(=O)O)N |
| TCMBANKIN059852 | 2-Methyl-1,4-dihydroxyanthraquinone | C15H10O4 | 254.24 g/mol | CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O | |
| TCMBANKIN059932 | chrysophanol | C15H10O4 | 254.24 | CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O | |
| TCMBANKIN059942 | Tectochinon | C15H10O2 | 222.24 g/mol | CC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O | |
| TCMBANKIN061729 | 7-o-methylaromadendrin | aromadendrin-7-monomethyl ether;7-Methoxy-aromadendrin;7-methoxy-aromadendrin | C16H14O6 | COC1=CC(=C2C(=C1)OC(C(C2=O)O)C3=CC=C(C=C3)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab